Access to anti-retroviral drugs, male (%) in Laos
Laos: Access to anti-retroviral drugs, male (%) was 61.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Laos, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Laos is 61.0%, measured in 2024. That is the highest value across all 24 years on record.
The figure is up 8.9% on the previous year and up 177.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Laos peaked at 61.0% in 2024 and was at its lowest, 0.0%, in 2000.
Laos ranks 97th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male (%) in Laos, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 3.0% | +200.0% |
| 2005 | 5.0% | +66.7% |
| 2006 | 7.0% | +40.0% |
| 2007 | 10.0% | +42.9% |
| 2008 | 12.0% | +20.0% |
| 2009 | 14.0% | +16.7% |
| 2010 | 15.0% | +7.1% |
| 2011 | 16.0% | +6.7% |
| 2012 | 18.0% | +12.5% |
| 2013 | 20.0% | +11.1% |
| 2014 | 22.0% | +10.0% |
| 2015 | 25.0% | +13.6% |
| 2016 | 28.0% | +12.0% |
| 2017 | 33.0% | +17.9% |
| 2018 | 37.0% | +12.1% |
| 2019 | 40.0% | +8.1% |
| 2020 | 44.0% | +10.0% |
| 2021 | 46.0% | +4.5% |
| 2022 | 50.0% | +8.7% |
| 2023 | 56.0% | +12.0% |
| 2024 | 61.0% | +8.9% |
Laos compared with similar countries
- Laos's 61.0% is below the median for lower middle income countries, which is 71.0%, 86% of the median. (39 countries reporting)
- Laos's 61.0% is below the median for East Asia & Pacific, which is 62.0%, 98% of the median. (15 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male (%) in Laos changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +200.0% | 1.0% | 3.0% |
| 2005 | +66.7% | 3.0% | 5.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.8% | 0.0% | 14.0% | 9 |
| 2010s | 25.4% | 15.0% | 40.0% | 10 |
| 2020s | 51.4% | 44.0% | 61.0% | 5 |
Countries ranked near Laos
- 94 Bhutan 62.0% compare
- 94 Guinea-Bissau 62.0% compare
- 94 East Timor 62.0% compare
- 97 Central African Republic 61.0% compare
- 97 Costa Rica 61.0% compare
- 97 Montenegro 61.0% compare
- 97 Paraguay 61.0% compare
More gender data for Laos
- Child population (UN estimates and projections) 2,335 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.3716 % change on previous year (2030)
- Population 6,022 (2030)
- Working-age population (UN estimates and projections) 6,022 (2030)
- Population (UN estimates and projections), annual growth rate 1.71 % change on previous year (2030)
- Age population, age 00, female, interpolated 77,014 (2025)
- Age population, age 00, male, interpolated 80,573 (2025)
- Age population, age 01, female, interpolated 76,875 (2025)
- Age population, age 01, male, interpolated 80,330 (2025)
- Age population, age 02, female, interpolated 76,857 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Laos?
- Access to anti-retroviral drugs, male in Laos was 61.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Laos?
- The highest recorded value was 61.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Laos?
- The lowest recorded value was 0.0% in 2000.
- How does Laos rank for access to anti-retroviral drugs, male?
- Laos ranks 97th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Laos?
- Over the last ten years it is up 177.3%. The long-run trend across the full record is volatile.
- Where does this Laos data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.